The CKD animals treated with sevelamer 6 weeks before the administration of LPS (CKD sev LPS group) had a lower plasmatic concentration of Il1b, TNFa and increased the RNA expression of FXR in the kidney compared to the CKD LPS group. The gene discussed is IL1B; the disease is chronic kidney disease.